From Iran To CEO Of A Biotech Startup, Bioniz, With No Revenue But A $400 Million Valuation
Nazli Azimi founded Bioniz Therapeutics, where she ' s developing new types of drugs to fight cancer and autoimmune diseases like celiac and alopecia. Her theory: attack so-called cytokines, the multiple proteins that block immune pathways.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Susan Adams, Forbes Staff Source Type: news
More News: Alopecia | Autoimmune Disease | Biotechnology | Cancer | Cancer & Oncology | Celiac Disease | Coeliac Disease | Iran Health | Middle East Health | Pharmaceuticals